{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:48:47Z","timestamp":1770979727578,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.amjcard.2005.07.011","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T07:20:52Z","timestamp":1133853652000},"page":"42-46","source":"Crossref","is-referenced-by-count":79,"special_numbering":"S2","title":["Pharmacology and Drug Interaction Effects of the Phosphodiesterase 5 Inhibitors: Focus on \u03b1-Blocker Interactions"],"prefix":"10.1016","volume":"96","author":[{"given":"Robert A.","family":"Kloner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.07.011_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0895-7061(00)01177-8","article-title":"Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy","volume":"14","author":"Kloner","year":"2001","journal-title":"Am J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2005.07.011_bib2","doi-asserted-by":"crossref","first-page":"A55","DOI":"10.1016\/S0895-7061(02)02415-9","article-title":"Safety of Viagra (sildenafil citrate) in men with erectile dysfunction and arterial hypertension who are taking multiple antihypertensive treatments","volume":"15","author":"Pickering","year":"2002","journal-title":"Am J Hypertens"},{"issue":"suppl 5A","key":"10.1016\/j.amjcard.2005.07.011_bib3","doi-asserted-by":"crossref","first-page":"29C","DOI":"10.1016\/S0002-9149(99)00045-4","article-title":"Efficacy and safety of sildenafil citrate in the treatment of ED in patients with ischemic heart disease","volume":"83","author":"Conti","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib4","first-page":"576","article-title":"Erectile dysfunction and sildenafil citrate and cardiologists","volume":"83","author":"Kloner","year":"1999","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2005.07.011_bib5","doi-asserted-by":"crossref","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","article-title":"Effects of sildenafil citrate on human hemodynamics","volume":"83","author":"Jackson","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib6","series-title":"Product monograph for Levitra (vardenafil hydrochloride)","year":"2003"},{"key":"10.1016\/j.amjcard.2005.07.011_bib7","doi-asserted-by":"crossref","first-page":"H32","DOI":"10.1016\/S1520-765X(02)90050-7","article-title":"Overview of the cardiovascular effects of tadalafil","volume":"4","author":"Emmick","year":"2002","journal-title":"Eur Heart J Suppl"},{"issue":"suppl","key":"10.1016\/j.amjcard.2005.07.011_bib8","doi-asserted-by":"crossref","first-page":"37M","DOI":"10.1016\/S0002-9149(03)00074-2","article-title":"Cardiovascular effects of tadalafil","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document use of sildenafil (Viagra) in patients with cardiovascular disease","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2005.07.011_bib11","doi-asserted-by":"crossref","first-page":"21C","DOI":"10.1016\/S0002-9149(99)00044-2","article-title":"Sildenafil citrate and blood\u2013pressure-lowering drugs","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"issue":"suppl 3","key":"10.1016\/j.amjcard.2005.07.011_bib12","first-page":"S22","article-title":"Interaction between glyceryl trinitrate and sildenafil citrate (Viagra) may last less than four hours","volume":"14","author":"Oliver","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.amjcard.2005.07.011_bib13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib14","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1001\/jama.290.23.3129","article-title":"Sexual activity in patients with angina","volume":"290","author":"DeBusk","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.07.011_bib15","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/00004872-200018120-00022","article-title":"Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication","volume":"18","author":"Zusman","year":"2000","journal-title":"J Hypertens"},{"issue":"suppl","key":"10.1016\/j.amjcard.2005.07.011_bib16","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/S0002-9149(03)00075-4","article-title":"Cardiovascular effects of tadalafil in patients on common antihypertensive therapies","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"issue":"suppl A","key":"10.1016\/j.amjcard.2005.07.011_bib17","doi-asserted-by":"crossref","first-page":"276A","DOI":"10.1016\/S0735-1097(03)82299-4","article-title":"Cardiovascular safety of vardenafil in patients receiving antihypertensive medications","volume":"41","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2005.07.011_bib18","doi-asserted-by":"crossref","first-page":"48A","DOI":"10.1016\/S0895-7061(02)02393-2","article-title":"Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in men with erectile dysfunction on antihypertensive therapy","volume":"15","author":"Padma-Nathan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjcard.2005.07.011_bib19","first-page":"418","article-title":"Influence of vardenafil on blood pressure and pharmacokinetics in hypertensive patients on nifedipine therapy","volume":"22","author":"Rohde","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjcard.2005.07.011_bib20","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.07.011_bib21","series-title":"Sildenafil prescribing information","year":"2004"},{"key":"10.1016\/j.amjcard.2005.07.011_bib22","unstructured":"Data on file. US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee: Levitra tablets. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/slides\/3956S1_03_Bayer_files\/frame.htm. Accessed September 5, 2003."},{"key":"10.1016\/j.amjcard.2005.07.011_bib23","doi-asserted-by":"crossref","first-page":"16A","DOI":"10.1016\/j.amjhyper.2004.03.034","article-title":"Co-administered vardenafil (for erectile dysfunction) and tamsulosin do not induce hypotension in patients with benign prostatic hypertrophy","volume":"17","author":"Auerbach","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjcard.2005.07.011_bib24","series-title":"Data on file","year":"2003"},{"key":"10.1016\/j.amjcard.2005.07.011_bib25","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/01.ju.0000142687.75577.e4","article-title":"Interaction between the phosphodiesterase 5 inhibitor, tadalafil, and the two alpha blockers","volume":"172","author":"Kloner","year":"2004","journal-title":"J Urol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905011264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914905011264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T07:27:05Z","timestamp":1547969225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914905011264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002914905011264"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.07.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}